Sign in

CIK 0001549595

  • Large accelerated filer

Nurix Therapeutics, Inc.

Sign in to watch
Ticker
NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Nov 30
Incorporated
DE
Entity type
Operating
EIN
270838048
Phone
+1 415-660-5320
Business address
1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
Former names
Nurix, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,712,859
in 10 filings, $1.0M under 10b5-1 plans

Net −$1,712,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 1 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-04-12 Beaurang Pierre Chief Business Officer Exercise or conversion · Employee Stock Option (right to buy) −2,396 0
2021-04-12 Beaurang Pierre Chief Business Officer Exercise or conversion · Employee Stock Option (right to buy) −5,104 36,562
2021-04-05 Hansen Gwenn Chief Scientific Officer Exercise or conversion +400 $7.26 $3K 14,204
2021-04-05 Hansen Gwenn Chief Scientific Officer Sale −400 $35.00 $14K 13,804
2021-04-05 Hansen Gwenn Chief Scientific Officer Exercise or conversion · Employee Stock Option (right to buy) −400 73,466
2021-04-01 Hansen Gwenn Chief Scientific Officer Exercise or conversion +400 $7.26 $3K 14,204
2021-04-01 Hansen Gwenn Chief Scientific Officer Sale −400 $31.55 $13K 13,804
2021-04-01 Hansen Gwenn Chief Scientific Officer Exercise or conversion · Employee Stock Option (right to buy) −400 73,866
2021-03-25 Beaurang Pierre Chief Business Officer Exercise or conversion +4,330 $0.84 $4K 4,330
2021-03-25 Beaurang Pierre Chief Business Officer Exercise or conversion · Employee Stock Option (right to buy) −4,330 2,396
2021-03-16 Hansen Gwenn Chief Scientific Officer Exercise or conversion +800 $7.26 $6K 14,604
2021-03-16 Hansen Gwenn Chief Scientific Officer Sale −800 $45.00 $36K 13,804
2021-03-16 Hansen Gwenn Chief Scientific Officer Exercise or conversion · Employee Stock Option (right to buy) −800 74,266
2021-03-10 Ring Christine General Counsel Exercise or conversion +2,000 $1.86 $4K 2,805
2021-03-10 Ring Christine General Counsel Sale −900 $39.44 $35K 1,905
2021-03-10 Ring Christine General Counsel Sale −300 $41.13 $12K 1,605
2021-03-10 Ring Christine General Counsel Sale −405 $42.67 $17K 1,200
2021-03-10 Ring Christine General Counsel Sale −395 $44.11 $17K 805
2021-03-10 Ring Christine General Counsel Exercise or conversion · Employee Stock Option (right to buy) −2,000 117,666
2021-03-08 Beaurang Pierre Chief Business Officer Exercise or conversion +7,500 $0.84 $6K 7,500

Page 37 of 42 · 829 trades